Pfizer strikes cancer drug deal with China's 3SBio Ruchika Sharma20 May 2025 11:30 AM IST3SBio plans to initiate the first Phase 3 study in China in 2025.
Roche receives USFDA approval for VENTANA MET (SP44) RxDx Assay as companion diagnostic in non-small cell lung cancer Ruchika Sharma18 May 2025 2:30 PM ISTBasel: Roche has announced that the FDA has approved the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic approved to aid in determining...
Bristol Myers Squibb bags European Commission approval for Opdivo combo in lung cancer treatment Ruchika Sharma18 May 2025 11:45 AM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has approved the perioperative regimen of neoadjuvant...
AbbVie Emrelis gets USFDA accelerated approval for a type of lung cancer Ruchika Sharma15 May 2025 11:10 AM ISTNorth Chicago: AbbVie has received accelerated approval from the U.S. Food and Drug Administration (FDA) for EMRELIS (telisotuzumab...
New radiotherapy technique may protect heart during lung cancer treatment: Study Dr. Kamal Kant Kohli14 May 2025 9:00 PM ISTA new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to evaluate the impact of...
GSK, partner iTeos end development programme for lung cancer drug belrestotug Ruchika Sharma14 May 2025 2:30 PM ISTGSK plc with its development partner iTeos Therapeutics, Inc., has announced that it is ending the development programme for experimental lung cancer...
Medical Bulletin 05/ May/ 2025 Dr. Garima Soni5 May 2025 3:00 PM ISTHere are the top medical news for the day:Too Much Chicken? New Research Finds Link to Increased Risk of Early DeathA recent study published in the...
AI-Enabled X-Rays Help Detect Lung Cancer Risk in 50,000 Patients Worldwide: Study Shows Dr. Garima Soni5 May 2025 8:30 AM ISTAstraZeneca, in partnership with health-tech company Qure.ai, has successfully completed over 5 million artificial intelligence (AI)-enabled chest...
Non-risk-based lung cancer screening with low-dose computed tomography: JAMA Dr. Kamal Kant Kohli3 May 2025 7:00 AM ISTIn 2015, the First Affiliated Hospital of Guangzhou Medical University, in collaboration with the Guangdong Hetaoxiang Medical Charity Foundation and...
Roche secures USFDA Breakthrough Device Designation for AI-driven companion diagnostic for non small cell lung cancer Ruchika Sharma29 April 2025 11:45 AM ISTBasel: Roche has announced that the VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer has received Breakthrough Device...
Breast and colorectal cancer screening rates nearly four-fold higher than lung cancer screening among those eligible: Study Dr. Kamal Kant Kohli17 April 2025 8:00 PM ISTLung cancer screening has the potential to catch lung cancer early and save lives-but only if people get screened. Although lung cancer screening is...
Cipla gets USFDA nod for Paclitaxel Protein bound Particles for Injectable Suspension Ruchika Sharma11 April 2025 11:30 AM ISTMumbai: Cipla has announced that the Company has received final approval from the United States Food and Drug Administration (USFDA) for the ...
